98 related articles for article (PubMed ID: 20116742)
21. Nutritional depletion and its relationship to respiratory impairment in patients with chronic respiratory failure due to COPD or restrictive thoracic diseases.
Budweiser S; Meyer K; Jörres RA; Heinemann F; Wild PJ; Pfeifer M
Eur J Clin Nutr; 2008 Mar; 62(3):436-43. PubMed ID: 17342162
[TBL] [Abstract][Full Text] [Related]
22. [COPD: what is there beyond BODE index?].
Casanova Macario C; de Torres Tajes JP; Lanus EC
Arch Bronconeumol; 2009; 45 Suppl 5():35-9. PubMed ID: 20116760
[TBL] [Abstract][Full Text] [Related]
23. [Multidimensional impact of COPD exacerbations].
Soler-Cataluña JJ; Martínez-García MÁ; Serra PC
Arch Bronconeumol; 2010 Dec; 46 Suppl 11():12-9. PubMed ID: 21316556
[TBL] [Abstract][Full Text] [Related]
24. Global assessment of the COPD patient: time to look beyond FEV1?
Papaioannou AI; Loukides S; Gourgoulianis KI; Kostikas K
Respir Med; 2009 May; 103(5):650-60. PubMed ID: 19167871
[TBL] [Abstract][Full Text] [Related]
25. Prognosis of COPD patients requiring frequent hospitalization: role of airway infection.
Renom F; Yáñez A; Garau M; Rubí M; Centeno MJ; Gorriz MT; Medinas M; Ramis F; Soriano JB; Alvar Agustí
Respir Med; 2010 Jun; 104(6):840-8. PubMed ID: 20106648
[TBL] [Abstract][Full Text] [Related]
26. Exercise-induced systemic effects in muscle-wasted patients with COPD.
Van Helvoort HA; Heijdra YF; Thijs HM; Viña J; Wanten GJ; Dekhuijzen PN
Med Sci Sports Exerc; 2006 Sep; 38(9):1543-52. PubMed ID: 16960513
[TBL] [Abstract][Full Text] [Related]
27. The role of patient-centered outcomes in the course of chronic obstructive pulmonary disease: how long-term studies contribute to our understanding.
Tashkin DP
Am J Med; 2006 Oct; 119(10 Suppl 1):63-72. PubMed ID: 16996901
[TBL] [Abstract][Full Text] [Related]
28. [Comorbidities in COPD].
de Miguel Díez J; García TG; Maestu LP
Arch Bronconeumol; 2010 Dec; 46 Suppl 11():20-5. PubMed ID: 21316557
[TBL] [Abstract][Full Text] [Related]
29. [The BODE index as a predictor of unfavourable prognosis in chronic obstructive pulmonary disease (by the results of a prospective study)].
Karoli NA; Rebrov AP
Ter Arkh; 2007; 79(3):11-4. PubMed ID: 17526187
[TBL] [Abstract][Full Text] [Related]
30. Circulating vascular endothelial growth factor and systemic inflammatory markers in patients with stable and exacerbated chronic obstructive pulmonary disease.
Valipour A; Schreder M; Wolzt M; Saliba S; Kapiotis S; Eickhoff P; Burghuber OC
Clin Sci (Lond); 2008 Oct; 115(7):225-32. PubMed ID: 18307413
[TBL] [Abstract][Full Text] [Related]
31. [Relationship between quality of life and BODE index of stable ex-smokers with chronic obstructive pulmonary disease].
Koblízek V; Salajka F; Cermáková E; Tomsová M; Pohnetalová D; Papousek P; Bartos V; Dobesová T; Paráková Z; Ruta J; Sedlák V
Vnitr Lek; 2009 Oct; 55(10):940-7. PubMed ID: 19947238
[TBL] [Abstract][Full Text] [Related]
32. [Comorbidities in patients with chronic obstructive pulmonary disease].
Burgel PR
Rev Prat; 2011 Jun; 61(6):796-8. PubMed ID: 21826927
[TBL] [Abstract][Full Text] [Related]
33. Genetic and biochemical markers of obstructive lung disease in the general population.
Dahl M
Clin Respir J; 2009 Apr; 3(2):121-2. PubMed ID: 20298391
[TBL] [Abstract][Full Text] [Related]
34. [Assessment and outcome parameters in COPD].
Dierkesmann R; Gillissen A; Lorenz J; Magnussen H; Mitfessel H; Morr H; Pfeifer M; Schultze-Werninghaus G; Steinkamp G; Teschler H; Voshaar T; Welte T; Worth H
Pneumologie; 2009 Jan; 63(1):49-55. PubMed ID: 19137503
[TBL] [Abstract][Full Text] [Related]
35. A 4-year trial of tiotropium in chronic obstructive pulmonary disease.
Tashkin DP; Celli B; Senn S; Burkhart D; Kesten S; Menjoge S; Decramer M;
N Engl J Med; 2008 Oct; 359(15):1543-54. PubMed ID: 18836213
[TBL] [Abstract][Full Text] [Related]
36. It's about time--directing our attention toward modifying the course of COPD.
Cazzola M; Hanania NA; Jones PW; Mahler DA; Make B; Ohar J; Rennard S
Respir Med; 2008 Jun; 102 Suppl 1():S37-48. PubMed ID: 18582796
[TBL] [Abstract][Full Text] [Related]
37. Consequences of physical inactivity in chronic obstructive pulmonary disease.
Hartman JE; Boezen HM; de Greef MH; Bossenbroek L; ten Hacken NH
Expert Rev Respir Med; 2010 Dec; 4(6):735-45. PubMed ID: 21128749
[TBL] [Abstract][Full Text] [Related]
38. Fixed airflow obstruction due to asthma or chronic obstructive pulmonary disease: 5-year follow-up.
Contoli M; Baraldo S; Marku B; Casolari P; Marwick JA; Turato G; Romagnoli M; Caramori G; Saetta M; Fabbri LM; Papi A
J Allergy Clin Immunol; 2010 Apr; 125(4):830-7. PubMed ID: 20227753
[TBL] [Abstract][Full Text] [Related]
39. Living with chronic obstructive pulmonary disease: part I. Struggling with meal-related situations: experiences among persons with COPD.
Odencrants S; Ehnfors M; Grobe SJ
Scand J Caring Sci; 2005 Sep; 19(3):230-9. PubMed ID: 16101851
[TBL] [Abstract][Full Text] [Related]
40. Predictors of mortality in chronic obstructive pulmonary disease.
Cote CG; Celli BR
Clin Chest Med; 2007 Sep; 28(3):515-24, v. PubMed ID: 17720040
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
